Results 41 to 50 of about 7,418 (172)
Leishmaniasis is an endemic disease in Iran. Since education to prevent the disease is important, this study aimed to determine the effect of educational intervention based on the PRECEDE-PROCEED model on preventive behaviors of cutaneous leishmaniosis ...
Ali Khani Jeihooni +3 more
doaj +1 more source
Sitamaquine is a 8-aminoquinoline in development for the treatment of visceral leishmaniasis by oral route, no activity being observed on the experimental cutaneous leishmaniasis experimental models.
Loiseau P.M., Cojean S., Schrével J.
doaj +1 more source
Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis
Leishmaniasis is a neglected protozoan disease affecting over 12 million people globally with no approved vaccines for human use. New World cutaneous leishmaniasis (CL) caused by L. mexicana is characterized by the development of chronic non-healing skin
Greta Volpedo +18 more
doaj +1 more source
Dicentrine, an aporphine alkaloid, exhibits potent in vitro antileishmanial activity against Leishmania species with high selectivity and low macrophage cytotoxicity. Mechanistic studies reveal that the compound triggers parasite death possibly by inducing mitochondrial membrane disruption and oxidative stress.
Camila S. de Freitas +9 more
wiley +1 more source
Leishmaniasis has several clinical forms: self-healing or chronic cutaneous leishmaniasis or post-kala-azar dermal leishmaniasis; mucosal leishmaniasis; and visceral leishmaniasis, which is fatal if left untreated.
Bruno Mendes Roatt +14 more
doaj +1 more source
Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. [PDF]
Tegumentary Leishmaniasis (TL) is endemic in Latin America, and Brazil contributes approximately 20 thousand cases per year. The pathogenesis of TL, however, is still not fully understood. Clinical manifestations vary from cutaneous leishmaniasis (CL) to
Lilian Motta Cantanhêde +8 more
doaj +1 more source
Murine T Cell‐Dependent Response Affects Leishmania amazonensis Amastigote Survival and Virulence
ABSTRACT Our group has previously described the infection course of Leishmania amazonensis in BALB/c and BALB/cnu/nu mice, which have distinct T‐cell dependent responses. In this study, lesion‐derived amastigotes exhibited differential protein expression in a host‐dependent manner.
Gustavo Henrique Corrêa Soares +2 more
wiley +1 more source
Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for visceral leishmaniasis (VL), but its clinical efficacy is limited in cutaneous leishmaniasis (CL) and HIV/VL co-infection.
Guilherme S. Ramos +11 more
doaj +1 more source
Insights Into the Biological Mechanisms and Multifunctional Health Benefits of Morelloflavone
Morelloflavone (MF), a biflavonoid from Garcinia and related species, exhibits broad human health benefits through antioxidant, anti‐inflammatory, anticancer, and metabolic regulatory effects. This review highlights its molecular mechanisms, biosynthesis, and emerging roles in chronic disease prevention, emphasizing systems biology and machine learning
Yi Liu +4 more
wiley +1 more source
Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis
SUMMARYWe have investigated the effect of qinghaosu (QHS, artemisinin) and its derivatives onLeishmania majorreplicationin vitroand on the disease development in mice infected withL. major. Artemisinin is effective against promastigotesin vitro, with an ED50(50% effective dose) at 7.5 × 10−7m.
D M, Yang, F Y, Liew
openaire +2 more sources

